DOW Q1 2026: $873M EBITDA Beat, Q2 Guide Steps to $2B on Middle East Supply Shock

Dow Inc. reported Q1 2026 operating EBITDA of $873M, a 16% beat versus the $750M guide issued at the January Q4 2025 call, and guided Q2 2026 EBITDA to ~$2.0B. That is more than double the Q1 print and 2.7x the Q4 2025 $741M baseline. The mechanism is not secret: management attributes the inflection directly to the Middle East conflict and Strait of Hormuz disruption, which has removed approximately half of global ethylene and polyethylene supply from the market. The baseline analysis published one day before earnings flagged the Iran-war windfall tape narrative as "inverted from every SEC filing." Management has now explicitly inverted that inversion. The Narrative-Reality Gap lens flips from DISCONNECTED to ALIGNED.

The Numbers

The Pricing Ladder

Polyethylene pricing increases flowing through Dow's Q2 guide and beyond:

• January 2026: +$0.05/lb (pre-conflict, modest cycle base)
• March 2026: +$0.10/lb (post-conflict, ACC records March as the record month for total PE sales, industry operating rates at 97%)
• April 2026: +$0.30/lb settled, baked into the $2.0B Q2 guide ($0.26/lb global margin improvement)
• May 2026: +$0.20/lb announced, NOT in the Q2 guide — represents additional upside

COO-to-CEO Karen Carter framed the impact as 3x the scale of Winter Storm Uri in 2021, which drove polyethylene pricing to mid-cycle and above over a six-month window. The supply-shock speed this time is faster than Uri because the source is geopolitical rather than weather-driven — there is no clean repair path to Hormuz transit. Dow shipped volume up 3% sequentially in Q1 despite those dynamics, with January/February solid and a sharp positive inflection in March.

Sadara: Equity Losses Suspended, Restructuring Active

Jeffrey Tate disclosed on the Q1 call that cumulative Sadara equity losses reached $1.4B, matching Dow's existing relevant obligations and commitments ($1.2B debt + $100M revolving credit + $100M letter of credit). Under U.S. GAAP (ASC 323), Dow is suspending further equity loss recognition. Cash commitments 2026-2038 are approximately $100M per year. Q1 Sadara equity loss impact: $115M. FY26 estimated pre-suspension: ~$400M.

This is a technically correct accounting treatment, not earnings management — but the implication is that roughly $400M of GAAP drag will NOT appear on FY26 income statements even as economic losses continue at the JV. The Fugazi Filter lens flags this as a watch-list item. Separately, Fitterling committed to finishing Sadara restructuring negotiations with Saudi Aramco before his transition to Executive Chair on July 1, with a midyear earnings update promised. The baseline Sadara-impairment market repriced modestly up from 0.25 to 0.30: equity loss suspension is not itself an impairment, but the commitment ceiling was hit simultaneously with an active restructuring timeline, which increases the probability of a formal impairment event by year-end.

Forecast Markets: One Resolved, Seven Updated

The Q1 EBITDA market resolution is particularly instructive: the $873M print was a clean earnings beat (+16% vs guide) that did NOT clear the $1.0B binary threshold. The baseline ensemble's 0.20 probability was well-calibrated — all nine models anchored on management's $750M guide and historical chemicals trough-quarter beat patterns of 10-20% (the actual 16% beat was squarely in that range). The models did not anticipate the March supply-shock inflection, but even with that tailwind Q1 fell short of $1.0B by $127M.

Signal Changes Across Seven Lenses

Ten signals moved post-earnings. Highlights:

• Myth Meter — NARRATIVE_REALITY_GAP: DISCONNECTED → ALIGNED. The baseline's primary finding inverted. Management directly confirmed Middle East supply disruption as the Q1/Q2 earnings driver. The tape narrative the lens had flagged as fabricated was instead early.
• Roadkill Radar — OPERATIONAL_EXECUTION: MEETING → ACCELERATING. 16% Q1 beat + step-change Q2 guide + T2O tracking ahead + first site transformation exceeded initial $50M projection (delivered $80M run-rate).
• Stress Scanner — FUNDING_FRAGILITY: MODERATE → MANAGEABLE. Q2 $2B guide implies leverage drops to ~2.6x from 4.4x baseline. Sadara exposure capped at $1.4B commitment.
• Moat Mapper — COMPETITIVE_POSITION: CONTESTED → DEFENSIBLE (conditional on disruption duration). Supply shock favors Americas footprint; European share-take evident.
• Black Swan Beacon — TAIL_RISK_SEVERITY: SEVERE → MATERIAL. Bankruptcy tail reduces; Sadara capped; new tail is rapid Hormuz reopening.
• Fugazi Filter — ACCOUNTING_INTEGRITY: QUESTIONABLE → STABLE (with Sadara suspension caveat). No kitchen-sink repeat; T2O disclosed with specificity.

Next Catalysts

• May $0.20/lb PE settlement — upside to Q2 $2B guide if settles; additional $400M+ annualized margin
• Strait of Hormuz status — any diplomatic progress reverses pricing tailwind
• Q2 2026 earnings (mid-late July) — primary test of $2B EBITDA guide and Sadara restructuring outcome
• July 1, 2026 CEO transition — Karen Carter first quarter as CEO
• Peer capacity rationalization — LYB, WLK, SHEL, BASF announcements would confirm cycle-turn thesis